Large gap with delayed quotes
|
Last quote
08/15/2026
-
02:00:00
|
Bid
08/14/2026 -
21:59:58
|
Bid Volume |
Ask
08/14/2026 -
21:59:58
|
Ask Volume |
|---|---|---|---|---|
|
33.19
+0.25
(
+0.76% )
|
33.16
|
3,800 |
33.22
|
300 |
Analysis date: 14.08.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 11.08.2026.
Interest
None
None
No stars since 28.07.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 03.07.2026 at a price of 37.44.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 24.07.2026.
4wk Rel Perf
-15.80%
-15.80%
The four-week dividend-adjusted underperformance versus SP500 is 15.80%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 02.06.2026.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.10%.
Mkt Cap in $bn
3.87
3.87
With a market capitalization between $2 & $8bn, VIKING THERAPEUTICS is considered a mid-cap stock.
G/PE Ratio
-0.58
-0.58
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-8.16
-8.16
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-4.69%
-4.69%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
19
19
Over the last seven weeks, an average of 19 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
80
80
For 1% of index variation, the stock varies on average by 0.80%.
Correlation
0.15
0.15
Stock movements are totally independent of index variations.
Value at Risk
18.82
18.82
The value at risk is estimated at USD 18.82. The risk is therefore 56.71%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
22.11.2024
22.11.2024